MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) — Immuron Restricted (ASX: IMC; NASDAQ: IMRN), an Australian primarily based and globally built-in biopharmaceutical firm is happy to advise our Chief Govt…
Tag:
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) — Immuron Restricted (ASX: IMC; NASDAQ: IMRN), an Australian primarily based and globally built-in biopharmaceutical firm is happy to advise our Chief Govt…